Proceedings of the Texas A&M Medical Student Grand Rounds

The Role of Mast Cell-Mediated Inflammation on IBS-Induced Abdominal Pain

July 7, 2020 Pavia Ann Muringathuparambil

Pavia Ann Muringathuparambil

Introduction: IBS is a gastrointestinal disease triggered by many factors. Symptoms vary greatly between patients, but abdominal pain and bloating are most common. While a specific cause has yet to be identified, many factors including gene mutations1,2, gut microbiome imbalances3, and mast cell hyperplasia4 are being investigated as possible causes. Studies done with the CACNA1H and Scn5a genes show mutations in these genes result in ion flow changes which cause overexcitation of primary afferent neurons and disruption of the action potentials respectively1,2. A study done on the gut microbiome showed IBS patients had increased levels of P. aeruginosa which may lead to alterations in sensitivity3. Studies done on the effect of mast cells show increased numbers in IBS patients and proximity to nociceptors. Methods: To assess CACNA1H gene function, KO mice were created. KO mice treated with dextran sodium sulfate (DSS) to induce IBS symptoms showed no sensitivity whereas WT mice showed sensitivity to the DSS1. To assess Scn5a gene function, it knocked down and results showed a decrease in slow wave peak amplitude when compared with WT mice2. Gut microbiome differences between healthy and IBS patients were determined via DGGE and PCR analysis of duodenal and fecal samples3. Mast cell expression was determined via immunofluorescence staining of intestinal biopsies and showed increased expression in the gut of IBS patients5. Results: The results of the study on CACNA1H KO mice showed that Ca2+ channels play a role in pain experienced by IBS patients. Similarly, decreases in slow wave peak amplitude in Scn5a gene knocked down mice show the disruption to normal action potentials which may result in disrupted gut motility. Increased P. aeruginosa found in IBS patients is known to inhibit protease activated receptors (PAR2) in the lungs, but its effect in the gut remains unknown3. However, if it does have a similar inhibitory effect in the gut, this would be interesting considering mast cell activation has an excitatory effect on PAR2 receptors in the gut6. Immunofluorescence staining of the biopsies showed increases in mast cells in the terminal ileum and proximal colon of IBS patients when compared to healthy individuals but no difference in expression in the distal colon5. Conclusion: The results of the studies discussed, further support IBS being a multifactorial disease. As such, the effects of P. aeruginosa and mast cells on PAR2 receptors should be further studied to better understand how these different factors are related.

  1.  Scanzi, J., Accarie, A., Muller, E., Pereira, B., Aissouni, Y., Goutte, M., … and Dapoigny, M. (2016). Colonic overexpression of the T-type calcium channel Cav3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients. Neurogastroenterology & Motility, 28(11), 1632–1640.
  2. Beyder, A., Gibbons, S. J., Mazzone, A., Strege, P. R., Saravanaperumal, S. A., Sha, L., … and Farrugia, G. (2016). Expression and function of the Scn5a-encoded voltage-gated sodium channel Nav5 in the rat jejunum. Neurogastroenterology & Motility, 28(1), 64–73.
  3. Kerckhoffs, Angèle P. M., et al. “Molecular Analysis of Faecal and Duodenal Samples Reveals Significantly Higher Prevalence and Numbers of Pseudomonas Aeruginosa in Irritable Bowel Syndrome.” Journal of Medical Microbiology, vol. 60, no. 2, 2011, pp. 236–245., doi:10.1099/jmm.0.022848-0.
  4. Barbara, G., & Stanghellini, V. (2004). Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. doi: https://doi.org/10.1053/j.gastro.2003.11.055
  5. Song, Jun, et al. “Mast Cell-Dependent Mesenteric Afferent Activation by Mucosal Supernatant From Different Bowel Segments of Guinea Pigs With Post-Infectious Irritable Bowel Syndrome.” Journal of Neurogastroenterology and Motility, vol. 21, no. 2, 2015, pp. 236–246., doi:10.5056/jnm14095.
  6. Aich, Anupam, et al. “Mast Cell-Mediated Mechanisms of Nociception.” International Journal of Molecular Sciences, vol. 16, no. 12, 2015, pp. 29069–29092., doi:10.3390/ijms161226151
Inflammation Microbiology
Previous Post

Use of Mesenchymal Stem Cell Therapy to Target Metalloproteinase Overactivity in Osteoarthritis of the Knee

Next Post

The Role of γδ T Cells in Mediating Angiotensin II-Induced Hypertension and Vascular Injury

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.